Liver fibrosis in biliary atresia

References

• Balistreri WF, Grand R, Hoofnagle JH et al. Biliary atresia: current concepts and research directions – summary of a symposium. Hepatology23, 1682–1692 (1996).
   PubMed Web of Science ®Google Scholar
• Chang HK, Park YJ, Koh H et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J. Pediatr. Gastroenterol. Nutr.49, 323–328 (2009).
   PubMedGoogle Scholar
• McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet355, 25–29 (2000).
   PubMed Web of Science ®Google Scholar
• Mills CO, Milkiewicz P, Muller M et al. Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR-rats. J. Hepatol.31, 678–684 (1999).
   PubMed Web of Science ®Google Scholar
• Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ. Epidemiology of biliary atresia: a population-based study. Pediatrics99, 376–382 (1997).
   PubMed Web of Science ®Google Scholar
• Narkewicz MR. Biliary atresia: an update on our understanding of the disorder. Curr. Opin. Pediatr.13, 435–440 (2001).
   PubMedGoogle Scholar
• Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology35, 1297–1304 (2002).
   PubMedGoogle Scholar
• Davenport M, Howard ER. Macroscopic appearance at portoenterostomy – a prognostic variable in biliary atresia. J. Pediatr. Surg.31, 1387–1390 (1996).
   PubMedGoogle Scholar
• Shteyer E, Ramm GA, Xu C, White FV, Shepherd RW. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation. J. Pediatr. Gastroenterol. Nutr.42, 93–99 (2006).
   PubMedGoogle Scholar
• Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J. Pediatr.144, 123–125 (2004).
   PubMedGoogle Scholar
• Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet374, 1704–1713 (2009).
   PubMed Web of Science ®Google Scholar
• Adrian JE, Kamps JAAM, Scherphof GL et al. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochim. Biophys. Acta1768, 1430–1439 (2007).
   PubMed Web of Science ®Google Scholar
• Bolkenius U, Hahn D, Gressner AM, Breitkopf K, Dooley S, Wickert L. Glucocorticoids decrease the bioavailability of TGF-β which leads to a reduced TGF-β signaling in hepatic stellate cells. Biochem. Biophys. Res. Commun.325, 1264–1270 (2004).
   PubMed Web of Science ®Google Scholar
• Caligiuri A, De Franco RM, Romanelli RG et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology124, 504–520 (2003).
   PubMedGoogle Scholar
• Caligiuri A, De Franco RM, Romanelli RG et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology124, 504–520 (2003).
   PubMedGoogle Scholar
• Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol.36, 200–209 (2002).
   PubMed Web of Science ®Google Scholar
• Chen A, Beno DW, Davis BH. Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription. J. Biol. Chem.271, 25994–25998 (1996).
   PubMedGoogle Scholar
• Dienstag JL, Goldin RD, Heathcote EJ et al. Histological outcome during long-term lamivudine therapy. Gastroenterology124, 105–117 (2003).
   PubMed Web of Science ®Google Scholar
• Hadziyannis SJ, Tassopoulos NC, Heathcote EJ et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N. Engl. J. Med.348, 800–807 (2003).
   PubMed Web of Science ®Google Scholar
• Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N. Engl. J. Med.339, 61–68 (1998).
   PubMed Web of Science ®Google Scholar
• Poynard T, McHutchison J, Manns M et al. Impact of pegylated interferon a-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology122, 1303–1313 (2002).
   PubMed Web of Science ®Google Scholar
• Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem.264, 16957–16962 (1989).
   PubMed Web of Science ®Google Scholar
• Chen A, Davis BH. The DNA binding protein BTEB mediates acetaldehyde-induced, jun N-terminal kinase-dependent αI(I) collagen gene expression in rat hepatic stellate cells. Mol. Cell. Biol.20, 2818–2826 (2000).
   PubMedGoogle Scholar
• Garcia-Trevijano ER, Iraburu MJ, Fontana L et al. Transforming growth factor β1 induces the expression of α1(I) procollagen mRNA by a hydrogen peroxide-C/EBPβ-dependent mechanism in rat hepatic stellate cells. Hepatology29, 960–970 (1999).
   PubMed Web of Science ®Google Scholar
• Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF α and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest.96, 2461–2468 (1995).
   PubMed Web of Science ®Google Scholar
• Kim Y, Ratziu V, Choi SG, Lalazar A et al. Transcriptional activation of transforming growth factor β1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J. Biol. Chem.273, 33750–33758 (1998).
   PubMed Web of Science ®Google Scholar
• Kojima S, Hayashi S, Shimokado K et al. Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells. Blood95, 1309–1316 (2000).
   PubMedGoogle Scholar
• Comporti M, Arezzini B, Signorini C, Sgherri C, Monaco B, Gardi C. F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis? Lab. Invest.85, 1381–1391 (2005).
   PubMedGoogle Scholar
• Gujral JS, Liu J, Farhood A, Hinson JA, Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am. J. Physiol. Gastrointest. Liver Physiol.286, G499–G507 (2004).
   PubMed Web of Science ®Google Scholar
• Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology43, S31–S44 (2006).
   PubMed Web of Science ®Google Scholar
• Rodrigues CM, Steer CJ. Mitochondrial membrane perturbations in cholestasis. J. Hepatol.32, 135–141 (2000).
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Devereaux MW, Khandwala R. Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat. Pediatr. Res.44, 397–401 (1998).
   PubMed Web of Science ®Google Scholar
• Kawamura K, Kobayashi Y, Kageyama F et al. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis. Am. J. Gastroenterol.95, 3596–3601 (2000).
   PubMed Web of Science ®Google Scholar
• Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol.202, 199–211 (2005).
   PubMed Web of Science ®Google Scholar
• Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin. Liver Dis.25, 433–449 (2005).
   PubMed Web of Science ®Google Scholar
• Shim H, Harris ZL. Genetic defects in copper metabolism. J. Nutr.133, 1527S–1531S (2003).
   Google Scholar
• Desmet V, Roskams T, Van EP. Ductular reaction in the liver. Pathol. Res. Pract.191, 513–524 (1995).
   PubMedGoogle Scholar
• Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin. Diagn. Pathol.15, 259–269 (1998).
   PubMed Web of Science ®Google Scholar
• LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver21, 73–80 (2001).
   PubMedGoogle Scholar
• Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology99, 466–477 (1990).
   PubMedGoogle Scholar
• Polimeno L, Azzarone A, Zeng QH et al. Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology21, 1070–1078 (1995).
   PubMedGoogle Scholar
• Alvaro D, Mancino MG, Glaser S et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology132, 415–431 (2007).
   PubMed Web of Science ®Google Scholar
• Diaz R, Kim JW, Hui JJ et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum. Pathol.39, 102–115 (2008).
   PubMed Web of Science ®Google Scholar
• Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int. J. Biochem. Cell Biol. DOI:10.1016/j.biocel.2009.11.006 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Libbrecht L, Desmet V, Van DB, Roskams T. Deep intralobular extension of human hepatic ‘progenitor cells’ correlates with parenchymal inflammation in chronic viral hepatitis: can ‘progenitor cells’ migrate? J. Pathol.192, 373–378 (2000).
   PubMed Web of Science ®Google Scholar
• Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol.154, 537–541 (1999).
   PubMed Web of Science ®Google Scholar
• Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science284, 1168–1170 (1999).
   PubMed Web of Science ®Google Scholar
• Preisegger KH, Factor VM, Fuchsbichler A, Stumptner C, Denk H, Thorgeirsson SS. Atypical ductular proliferation and its inhibition by transforming growth factor β1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab. Invest.79, 103–109 (1999).
   PubMed Web of Science ®Google Scholar
• Yang L, Faris RA, Hixson DC. Characterization of a mature bile duct antigen expressed on a subpopulation of biliary ductular cells but absent from oval cells. Hepatology18, 357–366 (1993).
   PubMedGoogle Scholar
• Yang L, Faris RA, Hixson DC. Phenotypic heterogeneity within clonogenic ductal cell populations isolated from normal adult rat liver. Proc. Soc. Exp. Biol. Med.204, 280–288 (1993).
   PubMedGoogle Scholar
• Kinnman N, Housset C. Peribiliary myofibroblasts in biliary type liver fibrosis. Front. Biosci.7, d496–d503 (2002).
   Web of Science ®Google Scholar
• Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology40, 1151–1159 (2004).
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Russo FP, Rey V et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology126, 955–963 (2004).
   PubMed Web of Science ®Google Scholar
• Suskind DL, Muench MO. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J. Hepatol.40, 261–268 (2004).
   PubMedGoogle Scholar
• Dalakas E, Newsome PN, Boyle S et al. Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev. DOI:10.1089/scd.2009.0387 (2009) (Epub ahead of print).
   Google Scholar
• Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol.45, 429–438 (2006).
   PubMed Web of Science ®Google Scholar
• Russo FP, Alison MR, Bigger BW et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology130, 1807–1821 (2006).
   PubMed Web of Science ®Google Scholar
• Del CG, Murillo MM, Avarez-Barrientos A et al. Autocrine production of TGF-β confers resistance to apoptosis after an epithelial–mesenchymal transition process in hepatocytes: role of EGF receptor ligands. Exp. Cell Res.312, 2860–2871 (2006).
   PubMedGoogle Scholar
• Ju W, Ogawa A, Heyer J et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol.26, 654–667 (2006).
   PubMed Web of Science ®Google Scholar
• Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem.282, 22089–22101 (2007).
   PubMed Web of Science ®Google Scholar
• Kojima T, Takano K, Yamamoto T et al. Transforming growth factor-β induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int.28, 534–545 (2008).
   PubMed Web of Science ®Google Scholar
• Valdes F, Alvarez AM, Locascio A et al. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor β in fetal rat hepatocytes. Mol. Cancer Res.1, 68–78 (2002).
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Yang C, Martino M et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem.282, 23337–23347 (2007).
   PubMed Web of Science ®Google Scholar
• Mack CL, Falta MT, Sullivan AK et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology133, 278–287 (2007).
   PubMed Web of Science ®Google Scholar
• Ohya T, Fujimoto T, Shimomura H, Miyano T. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J. Pediatr. Surg.30, 515–518 (1995).
   PubMed Web of Science ®Google Scholar
• Schweizer P, Petersen M, Jeszberger N, Ruck P, Dietz K. Immunohistochemical and molecular biological investigations regarding the pathogenesis of extrahepatic biliary atresia. (Part 1: immunohistochemical studies). Eur. J. Pediatr. Surg.13, 7–15 (2003).
   PubMed Web of Science ®Google Scholar
• Ahmed AF, Ohtani H, Nio M et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J. Pathol.193, 383–389 (2001).
   PubMedGoogle Scholar
• Dillon P, Belchis D, Tracy T, Cilley R, Hafer L, Krummel T. Increased expression of intercellular adhesion molecules in biliary atresia. Am. J. Pathol.145, 263–267 (1994).
   PubMed Web of Science ®Google Scholar
• Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J. Exp. Med.181, 33–40 (1997).
   PubMedGoogle Scholar
• Kobayashi H, Puri P, O’Briain DS, Surana R, Miyano T. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J. Pediatr. Surg.32, 590–593 (1997).
   PubMed Web of Science ®Google Scholar
• Shivakumar P, Campbell KM, Sabla GE et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-γ in experimental biliary atresia. J. Clin. Invest.114, 322–329 (2004).
   PubMed Web of Science ®Google Scholar
• Shivakumar P, Sabla G, Mohanty S et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology133, 268–277 (2007).
   PubMed Web of Science ®Google Scholar
• Muraji T, Suskind DL, Irie N. Biliary atresia: a new immunological insight into etiopathogenesis. Expert Rev. Gastroenterol. Hepatol.3, 599–606 (2009).
   PubMedGoogle Scholar
• Balistreri WF, Grand R, Hoofnagle JH et al. Biliary atresia: current concepts and research directions – summary of a symposium. Hepatology23, 1682–1692 (1996).
   PubMed Web of Science ®Google Scholar
• Liu C, Chiu JH, Chin T et al. Expression of fas ligand on bile ductule epithelium in biliary atresia – a poor prognostic factor. J. Pediatr. Surg.35, 1591–1596 (2000).
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin. Liver Dis.21, 517–524 (2001).
   PubMed Web of Science ®Google Scholar
• Urushihara N, Iwagaki H, Yagi T et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J. Pediatr. Surg.35, 446–449 (2000).
   PubMed Web of Science ®Google Scholar
• Davenport M, Gonde C, Redkar R et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J. Pediatr. Surg.36, 1017–1025 (2001).
   PubMed Web of Science ®Google Scholar
• Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am. J. Pathol.153, 527–535 (1998).
   PubMed Web of Science ®Google Scholar
• Faiz Kabir Uddin Ahmed A, Ohtani H, Nio M et al. In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages. J. Pathol.192, 73–80 (2000).
   PubMed Web of Science ®Google Scholar
• Seki E, De MS, Osterreicher CH et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med.13, 1324–1332 (2007).
   PubMed Web of Science ®Google Scholar
• Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest.115, 56–65 (2005).
   PubMed Web of Science ®Google Scholar
• Rivera CA, Bradford BU, Hunt KJ et al. Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am. J. Physiol. Gastrointest. Liver Physiol.281, G200–G207 (2001).
   Google Scholar
• Lamireau T, Le BB, Boussarie L et al. Expression of collagens type I and IV, osteonectin and transforming growth factor β-1 (TGFβ1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. J. Hepatol.31, 248–255 (1999).
   PubMedGoogle Scholar
• Pape L, Olsson K, Petersen C, von Wasilewski R, Melter M. Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transpl.15, 876–882 (2009).
   PubMed Web of Science ®Google Scholar
• Tanano H, Hasegawa T, Kimura T et al. Proposal of fibrosis index using image analyzer as a quantitative histological evaluation of liver fibrosis in biliary atresia. Pediatr. Surg. Int.19, 52–56 (2003).
   PubMedGoogle Scholar
• Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch. Intern. Med.139, 667–669 (1979).
   PubMedGoogle Scholar
• Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol.97, 2614–2618 (2002).
   PubMed Web of Science ®Google Scholar
• Tamatani T, Kobayashi H, Tezuka K et al. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem. Biophys. Res. Commun.251, 748–752 (1998).
   PubMed Web of Science ®Google Scholar
• Jiang CB, Lee HC, Yeung CY et al. A scoring system to predict the need for liver transplantation for biliary atresia after Kasai portoenterostomy. Eur. J. Pediatr.162, 603–606 (2003).
   PubMed Web of Science ®Google Scholar
• Olthoff KM, Brown RS Jr, Delmonico FL et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. December 8, (2003), Washington, DC, USA. Liver Transpl.10, A6–A22 (2004).
   PubMed Web of Science ®Google Scholar
• Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology134, 1670–1681 (2008).
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol.29, 1705–1713 (2003).
   PubMed Web of Science ®Google Scholar
• de Lédinghen V, Le Bail B, Rebouissoux L et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J. Pediatr. Gastroenterol. Nutr.45, 443–450 (2007).
   PubMed Web of Science ®Google Scholar
• Huwart L, Salameh N, ter Beek L et al. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur. Radiol.18, 2535–2541 (2008).
   PubMedGoogle Scholar
• Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem. J.411, 1–18 (2008).
   PubMed Web of Science ®Google Scholar
• Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev. Gastroenterol. Hepatol.2, 803–816 (2008).
   PubMedGoogle Scholar
• Kotb MA. Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. J. Pediatr. Surg.43, 1321–1327 (2008).
   PubMed Web of Science ®Google Scholar
• Willot S, Uhlen S, Michaud L et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics122, e1236–e1241 (2008).
   PubMed Web of Science ®Google Scholar
• Escobar MA, Jay CL, Brooks RM et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J. Pediatr. Surg.41, 99–103 (2006).
   PubMed Web of Science ®Google Scholar
• Meyers RL, Book LS, O’Gorman MA et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J. Pediatr. Surg.38, 406–411 (2003).
   PubMed Web of Science ®Google Scholar
• Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology46, 1821–1827 (2007).
   PubMed Web of Science ®Google Scholar
• Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J. Pediatr. Surg.32, 1103–1106 (1997).
   PubMedGoogle Scholar